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Obesity is well recognized to increase the risk of several types of 
cancer [1]. It has been suggested that those of 25% over normal weight 
have a 33% greater cancer risk than those who maintain a normal body 
weight [2]. There is ample evidence that weight control via decreasing 
calorie intake and/or increasing physical activity reduces cancer risk. 
For almost a century, Dietary Calorie Restriction (DCR) has been 
shown to inhibit the development of almost all types of cancer in animal 
models [3]. Alternatively, exercise has also been shown to reduce some 
types of cancer [4]. When compared with DCR, however, the impact of 
exercise may demonstrate a modest but intricate result for both weight 
maintenance and cancer prevention. Our previous studies conducted 
in an animal model, for example, showed that treadmill exercise alone 
with ad libitum feeding was not sufficient to decrease body weight 
due to, at least in part, the corresponding increase in dietary intake 
[5]. If the food intake of the exercised mice was limited by iso-caloric 
intake with sedentary counterpart, then body weight and body fat 
were significantly reduced [6]. Indeed, a negative calorie homeostasis 
appears to be the most potent for preventing cancer, which may be even 
extrapolated from the greatest of weight control diets to many dietary 
cancer preventive factors such as whole grain, fiber, and resistant 
starch, as well as vegetables and/or fruits, etc. 
The mechanism by which weight control may reduce cancer risk 
is not well defined. Recently the National Cancer Institute called 
for research proposals regarding 24 Provocative Questions (http:// 
provocativequestions.nci.nih.gov). The number one question is how 
obesity contributes to cancer risk. Previous studies by us and others 
have found that weight loss is associated with a reduction of many 
plasma levels of hormones such as IGF-1, leptin, insulin, and thyroid 
hormones [7,8]. It is possible that the reduction of these hormones 
accounts for cancer prevention by weight loss due to a mitogenic 
role, especially by IGF-1 and leptin, in promoting cellular growth and 
metabolic complications [9]. 
As a mitogen, IGF-1 is well known to stimulate cell proliferation, 
inhibit apoptosis, and enhance angiogenesis. Chronically high 
levels of IGF-1 observed in obese subjects have been linked with an 
increased risk of developing several types of cancer in case-control 
and prospective cohort studies [10,11]. It has been suggested that the 
role of IGF-1 in mitogenesis is triggered through cellular signaling 
cascades leading to the activation of both IGF-1 dependent MAPK-
proliferation and PI3K-anti-apoptosis pathways for cancer promotion 
[12]. Furthermore, the role of adipocytes on malignance has been 
suggested via tumor-stroma interaction required during metastases or 
early micrometastases [13]. Recent data also suggest that adipocytes 
not only respond to hormonal signals, but also produce hormone-like 
factors such as pro-inflammatory leptin that may enhance oncological 
risk [14]. Although it is not clear how leptin interacts in IGF-1 
mitogenic signaling, our previous studies conducted in TPA-promoted 
mouse skin cancer model have demonstrated that the reduction of both 
IGF-1 and leptin levels in response to weight loss corresponded to a 
concomitant inhibition of IGF-1-dependent mitogenic cascades and 
thus diminution of TPA-promoted signaling [5,6,15]. 
In addition to fundamentally advancing in the fields of obesity 
and cancer research, better understanding of the relationship between 
weight control, endocrine hormones, and hormone-dependent signal 
pathways may lead to a novel approach for cancer prevention. 
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